Integrated BioPharma Inc. (OTCMKTS:INBP) Sees Significant Increase in Short Interest

Integrated BioPharma Inc. (OTCMKTS:INBP) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 4 shares, an increase of ∞ from the August 15th total of 0 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 12,617 shares, the days-to-cover ratio is presently 0.0 days.

Integrated BioPharma Stock Performance

OTCMKTS INBP opened at $0.17 on Tuesday. The business has a 50 day simple moving average of $0.17 and a 200 day simple moving average of $0.22. The stock has a market cap of $5.27 million, a price-to-earnings ratio of -2.43 and a beta of 0.40. Integrated BioPharma has a 52-week low of $0.14 and a 52-week high of $0.42.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.